MarketCap
Facebook
X
Telegram
Quaker Chemical Corporation Balance Sheet 2025-2008 | KWR
Brief overview of Quaker Chemical Corporation's balance sheet strength
The review uses the five latest available annual reports between 2021 and 2025.
The asset base decreased -5.3%, from $3 billion to $2.8 billion. Resources became smaller over the five periods.
Liabilities followed the scale of the balance sheet: -9.3% versus -5.3% for assets. Leverage did not change materially.
Equity represents 49.1% of assets versus 47% initially. The capital structure appears balanced.
Net debt to equity stands at 0.49x; the current burden does not look excessive.
Cash equals 6.4% of the balance sheet, compared with 5.6% five periods ago. This is the readily available cushion.
Accumulated earnings ended at $596.6 million, a change of +15.5%. They remain an important part of the capital base.
What the balance sheet shows
Quaker Chemical Corporation's balance sheet is broadly resilient, though selected areas require monitoring. The balance between assets, equity and liabilities remains the key issue.
Annual Balance Sheet Quaker Chemical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
668 M | 491 M | 548 M | 765 M | 681 M | 678 M | 797 M | -67.5 M | -23.1 M | -22.3 M | 1.05 M | 11 M | -49.8 M | - | 10.9 M | 56.9 M | - | - |
Long Term Debt |
835 M | 670 M | 731 M | 934 M | 836 M | 849 M | 882 M | 35.9 M | 61.1 M | 65.8 M | 81.4 M | 75.3 M | 17.3 M | - | 33.6 M | 73.9 M | - | - |
Long Term Debt Current |
12.5 M | 10.6 M | 12 M | 12 M | 9.98 M | 10.9 M | 11.2 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 1.25 B | 122 M | 158 M | 152 M | 180 M | 175 M | 108 M | - | 118 M | - | - | - |
Total Current Liabilities |
380 M | 380 M | 368 M | 355 M | 430 M | 383 M | 360 M | 151 M | 155 M | 127 M | 125 M | 125 M | 131 M | 108 M | 107 M | 101 M | - | - |
Total Liabilities |
1.42 B | 1.26 B | 1.33 B | 1.54 B | 1.57 B | 1.57 B | 1.61 B | 273 M | 313 M | 279 M | 304 M | 300 M | 239 M | - | 237 M | 262 M | - | - |
Deferred Revenue |
4.83 M | 3.86 M | 2.45 M | 6.58 M | 7.96 M | 6.38 M | 5.55 M | 2.19 M | 1.51 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
597 M | 634 M | 551 M | 470 M | 516 M | 424 M | 413 M | 405 M | 366 M | 364 M | 327 M | 300 M | 259 M | - | 159 M | 144 M | - | - |
Total Assets |
2.8 B | 2.61 B | 2.71 B | 2.82 B | 2.96 B | 2.89 B | 2.85 B | 710 M | 722 M | 692 M | 686 M | 666 M | 584 M | - | 491 M | 453 M | - | - |
Cash and Cash Equivalents |
180 M | 189 M | 195 M | 181 M | 165 M | 182 M | 124 M | 104 M | 89.9 M | 88.8 M | 81.1 M | 64.7 M | 68.5 M | 32.5 M | 16.9 M | 16.9 M | 25.1 M | 20.9 M |
Book Value |
1.38 B | 1.35 B | 1.38 B | 1.28 B | 1.39 B | 1.32 B | 1.24 B | 436 M | 410 M | 413 M | 381 M | 365 M | 345 M | - | 254 M | 191 M | - | - |
Total Shareholders Equity |
1.37 B | 1.35 B | 1.38 B | 1.28 B | 1.39 B | 1.32 B | 1.24 B | 435 M | 408 M | 403 M | 373 M | 357 M | 336 M | 281 M | 249 M | 180 M | 159 M | - |
All numbers in USD currency
Quarterly Balance Sheet Quaker Chemical Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
858 M | 837 M | 835 M | 839 M | 898 M | 699 M | 670 M | 701 M | 704 M | 740 M | 731 M | 805 M | 864 M | 922 M | 934 M | 931 M | - | 858 M | 836 M | 839 M | 847 M | 859 M | 849 M | 849 M | 849 M | 849 M | 882 M | 882 M | 882 M | 882 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 61.1 M | 61.1 M | 61.1 M | 61.1 M | 65.8 M | 65.8 M | 65.8 M | 65.8 M | 81.4 M | 81.4 M | 81.4 M | 81.4 M | 75.3 M | 75.3 M | 75.3 M | 75.3 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 30 M | 30 M | 30 M | 30 M | 46.7 M | 46.7 M | 46.7 M | 46.7 M |
Total Liabilities |
1.47 B | 1.42 B | 1.42 B | 1.45 B | 1.5 B | 1.28 B | 1.26 B | 1.29 B | 1.28 B | 1.32 B | 1.33 B | 1.39 B | 1.45 B | 1.54 B | 1.54 B | 1.55 B | - | 1.6 B | 1.57 B | 1.56 B | 1.57 B | 1.58 B | 1.57 B | 1.57 B | 1.57 B | 1.57 B | 1.61 B | 1.61 B | 1.61 B | 1.61 B | 273 M | 273 M | 273 M | 273 M | 313 M | 313 M | 313 M | 313 M | 279 M | 279 M | 279 M | 279 M | 299 M | 301 M | 301 M | 301 M | 300 M | 300 M | 300 M | 300 M | 239 M | 239 M | 239 M | 239 M | 247 M | 247 M | 247 M | 247 M | 250 M | 250 M | 250 M | 250 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.96 M | - | - | - | 6.38 M | - | - | - | 5.55 M | - | - | - | 2.19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
626 M | 607 M | 597 M | 585 M | 563 M | 638 M | 634 M | 628 M | 604 M | 578 M | 551 M | 539 M | 513 M | 492 M | 470 M | 554 M | - | 529 M | 516 M | 506 M | 482 M | 455 M | 424 M | 424 M | 424 M | 424 M | 413 M | 413 M | 413 M | 413 M | 405 M | 405 M | 405 M | 405 M | 366 M | 365 M | 365 M | 365 M | 364 M | 364 M | 364 M | 364 M | 327 M | 327 M | 327 M | 327 M | 300 M | 300 M | 300 M | 300 M | 258 M | 258 M | 258 M | 258 M | 215 M | 215 M | 215 M | 215 M | 181 M | 176 M | 176 M | 176 M |
Total Assets |
2.85 B | 2.8 B | 2.8 B | 2.82 B | 2.85 B | 2.66 B | 2.61 B | 2.74 B | 2.67 B | 2.71 B | 2.71 B | 2.73 B | 2.79 B | 2.86 B | 2.82 B | 2.83 B | - | 3 B | 2.96 B | 2.94 B | 2.94 B | 2.91 B | 2.89 B | 2.89 B | 2.89 B | 2.89 B | 2.85 B | 2.85 B | 2.85 B | 2.85 B | 710 M | 710 M | 710 M | 710 M | 722 M | 722 M | 722 M | 722 M | 692 M | 692 M | 692 M | 692 M | 681 M | 682 M | 682 M | 682 M | 664 M | 666 M | 666 M | 666 M | 584 M | 584 M | 584 M | 584 M | 537 M | 537 M | 537 M | 537 M | 511 M | 506 M | 506 M | 506 M |
Cash and Cash Equivalents |
155 M | 170 M | 180 M | 172 M | 202 M | 186 M | 189 M | 212 M | 189 M | 196 M | 195 M | 198 M | 189 M | 190 M | 181 M | 139 M | 202 M | 162 M | 165 M | 141 M | 146 M | 163 M | 182 M | 182 M | 182 M | 182 M | 124 M | 124 M | 124 M | 124 M | 104 M | 104 M | 104 M | 104 M | 89.9 M | 89.9 M | 89.9 M | 89.9 M | 88.8 M | 88.8 M | 88.8 M | 88.8 M | 81.1 M | 81.1 M | 81.1 M | 81.1 M | 64.7 M | 64.7 M | 64.7 M | 64.7 M | 68.5 M | 68.5 M | 68.5 M | 68.5 M | 32.5 M | 32.5 M | 32.5 M | 32.5 M | 32.5 M | 16.9 M | 16.9 M | 16.9 M |
Book Value |
1.38 B | 1.38 B | 1.38 B | 1.37 B | 1.35 B | 1.39 B | 1.35 B | 1.45 B | 1.4 B | 1.39 B | 1.38 B | 1.34 B | 1.34 B | 1.32 B | 1.28 B | 1.28 B | - | 1.4 B | 1.39 B | 1.38 B | 1.38 B | 1.33 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.24 B | 1.24 B | 1.24 B | 1.24 B | 436 M | 436 M | 436 M | 436 M | 410 M | 409 M | 409 M | 409 M | 413 M | 413 M | 413 M | 413 M | 381 M | 381 M | 381 M | 381 M | 364 M | 365 M | 365 M | 365 M | 345 M | 345 M | 345 M | 345 M | 290 M | 290 M | 290 M | 290 M | 261 M | 256 M | 256 M | 256 M |
Total Shareholders Equity |
1.38 B | 1.38 B | 1.37 B | 1.36 B | 1.34 B | 1.39 B | 1.35 B | 1.45 B | 1.4 B | 1.39 B | 1.38 B | 1.34 B | 1.34 B | 1.32 B | 1.28 B | 1.28 B | 1.33 B | 1.4 B | 1.39 B | 1.38 B | 1.38 B | 1.33 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.24 B | 1.24 B | 1.24 B | 1.24 B | 435 M | 435 M | 435 M | 435 M | 408 M | 407 M | 407 M | 407 M | 403 M | 403 M | 403 M | 403 M | 373 M | 373 M | 373 M | 373 M | 357 M | 357 M | 357 M | 357 M | 336 M | 336 M | 336 M | 336 M | 281 M | 281 M | 281 M | 281 M | 254 M | 249 M | 249 M | 249 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Quaker Chemical Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
China
USA
Canada
Britain
Niderland
Luxembourg
